Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis - Trial NCT06412094
Access comprehensive clinical trial information for NCT06412094 through Pure Global AI's free database. This phase not specified trial is sponsored by Avanta Trading Ltd. and is currently Completed. The study focuses on Atopic Dermatitis. Target enrollment is 66 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Avanta Trading Ltd.
Timeline & Enrollment
N/A
Mar 01, 2022
Dec 26, 2022
Primary Outcome
Patient Oriented Eczema Measure (POEM),SCORAD (SCORing Atopic Dermatitis)
Summary
A randomized controlled study in children with AD, divided into three groups: a control group
 without access to the app, an experimental observational group with the app, and an
 experimental interventional group with potential investigator supervision. Outcome measures
 included the SCORAD and the POEM scores.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06412094
Non-Device Trial